Completed NA INTERVENTIONAL 2-arm NCT06309420

Clinical Trial to Evaluate Efficacy and Safety of a Cryogenic Medical Device for Treatment of Common and Plantar Warts

Prospective, Single-blinded, Randomized Trial to Evaluate the Efficacy of a Cryogenic Medical Device in Treatment of Common and Plantar Warts Versus a Comparator Product.

Sponsor: Oystershell NV

Conditions Warts

Interventions Cryogenic treatment of warts (Pixie CO2) Cryogenic treatment of warts (Wortie®)

Updated 3 times since 2024 Last updated: Mar 7, 2024 Started: Nov 7, 2019 Primary completion: Aug 10, 2020 Completion: Aug 10, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Warts and is currently completed. Oystershell NV leads this study, which shows 3 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Apr 2024 — Jul 2024 [monthly]

Completed NA

First recorded

Nov 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Oystershell NV

Data source: Oystershell NV

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Gdansk, Poland